ulifloxacin has been researched along with sparfloxacin in 1 studies
| Studies (ulifloxacin) | Trials (ulifloxacin) | Recent Studies (post-2010) (ulifloxacin) | Studies (sparfloxacin) | Trials (sparfloxacin) | Recent Studies (post-2010) (sparfloxacin) |
|---|---|---|---|---|---|
| 50 | 3 | 15 | 694 | 69 | 79 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mitsuhashi, S; Yoshida, T | 1 |
1 other study(ies) available for ulifloxacin and sparfloxacin
| Article | Year |
|---|---|
Antibacterial activity of NM394, the active form of prodrug NM441, a new quinolone.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Dioxolanes; Enoxacin; Fluoroquinolones; Microbial Sensitivity Tests; Mutation; Naphthyridines; Ofloxacin; Piperazines; Quinolones; Topoisomerase II Inhibitors | 1993 |